Skip to product information
1 of 1

Biotin Mouse Anti-Human NKp44 (CD336) Antibody (S-3122)

Biotin Mouse Anti-Human NKp44 (CD336) Antibody (S-3122)

Catalog Number: S0B5813 Application: FCM Reactivity: Human Conjugation: Biotin Brand: Starter
Price:
Regular price $70 USD
Regular price Sale price $70 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen NKp44 (CD336)
Synonyms Natural cytotoxicity triggering receptor 2; Lymphocyte antigen 95 homolog; NK cell-activating receptor; Natural killer cell p44-related protein (NK-p44; NKp44); LY95; NCR2
Location Cell membrane
Accession O95944
Clone Number S-3122
Antibody Type Mouse mAb
Isotype IgG1,k
Application FCM
Reactivity Hu
Purification Protein G
Concentration 0.2 mg/ml
Conjugation Biotin
Physical Appearance Liquid
Storage Buffer

PBS, 0.3% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 5μl per million cells in 100μl volume Hu

Background

NKp44 (CD336, NCR2) is a 44-kDa type I transmembrane glycoprotein of the immunoglobulin superfamily expressed exclusively on activated human NK cells (induced by IL-2 or IL-15) and on minor subsets of γδ T cells, ILC1/3 and plasmacytoid dendritic cells; it functions as an activating natural cytotoxicity receptor that, upon engagement with still-undefined cellular ligands, associates via a positively charged transmembrane residue with the ITAM-bearing adaptor DAP12 (KARAP) to trigger NK-cell cytotoxicity and secretion of IFN-γ and TNF-α against tumor or virus-infected targets, while a cytoplasmic ITIM sequence can also mediate inhibitory signals, giving the receptor dual functionality and making its selective expression a key activation marker whose reduction, as seen in HIV infection, correlates with impaired NK-cell activity.

Picture

FC

Flow cytometric analysis of Human NKp44 (CD336) expression on untreated and treated Human PBMC (human peripheral blood mononuclear cells). Human PBMC (human peripheral blood mononuclear cells) were either untreated (Left panel) or treated 3 days (Right panel) with 1 ng/ml IL-2 and then stained with APC Mouse Anti-Human CD56 and SDT Biotin Mouse Anti-Human NKp44 (CD336) Antibody at 5 μl/test followed by Sav-PE. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)